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Background
IgE mediated allergy to fish is a cause of severe anaphy-
latic reactions. Parvalbumins are considered major fish
allergens and also responsible for cross-reactivity.
Objective
Evaluation of tolerance acquisition using the recombinant
fish parvalbumin (Gad c 1) in a group of fish allergic
patients (pts).
Material and methods
We selected 55 pts (34M, 21F; average age:7.4 years). All
had fish allergy, characterized by positive clinical history,
skin-prick tests and serum specific IgE to several fish and
Gad c 1 (UniCap®, Thermo-Fisher). Oral food challenge
was performed to evaluate fish tolerance acquisition. Statis-
tical analysis was performed using GraphPad Prisma version
5.0 (GraphPad Software Inc, SD). Two groups were com-
pared using a paired t test Wilcoxon. P values<0.05 were
considered significant.
Results
The 55 fish allergic pts had clinical symptoms for more
than one fish species: 43 (78%) pts had skin manifestations,
12 (22%) anaphylaxis, 8 (15%) respiratory and 9 (16%) gas-
trointestinal symptoms. Pts who suffered anaphylaxis had
lower Gad c 1 average values (31 KU/L) than the others
(76.7 KU/L); p=0.15. 38/55 (69%) pts were intolerant and
17/55 (31%) pts tolerated at least one fish species. Gad c 1
average values were significantly higher (21.6 KU/L) in the
intolerant group than in the partially tolerant group (2.7
KU/L); p=0.009. 24/38 pts were followed for at least one
year, on average 3.7 years. 14/24 pts developed fish toler-
ance to at least one fish species-Group I (10M, 4F; average
age 7 years) and 10/24 were intolerant-Group II (6M, 4F;
average age 7 years). Group I showed lower average values
(4.6 KU/L) of Gad c 1 than the Group II (25.1 KU/L);
p=0.0001.
Conclusions
Lower Gad c 1 values seem to be an important predictive
parameter in fish tolerance acquisition but not in predict-
ing clinical symptoms’ severity and might be considered a
useful tool in the follow-up of fish allergic patients.
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